[1]
Debendra Suman et al. 2025. COST-EFFECTIVENESS AND QUALITY-OF-LIFE OUTCOMES OF MONTELUKAST–LEVOCETIRIZINE VERSUS MONTELUKAST–BILASTINE IN ALLERGIC RHINITIS: A PROSPECTIVE OBSERVATIONAL STUDY. Journal of Population Therapeutics and Clinical Pharmacology. 32, 8 (Sep. 2025), 951–957. DOI:https://doi.org/10.53555/zh3ckf13.